张虎

摘要：目的：分析中西医结合治疗慢阻肺发作期的临床效果。方法：抽选2020年4月-2021年4月于本院诊治的76例慢阻肺发作期病例，双盲法划入基础组与结合组（n=38）。基础组应用常规西医治疗，结合组实施中西医结合治疗，对比两组病例的恢复情况。结果：治疗后两组患者的肺功能指标均得到改善，其中结合组病例的FEV1及PEF指标改善效果更加显著，优于基础组（p<0.05）。结合组病例的症状缓解率是97.37%，基础组病例的症状缓解率是81.58%，结合组的症状缓解率相对较高（p<0.05）。结论：中西医结合治疗可有效改善慢阻肺发作期患者的肺功能状态，临床治疗有效率较高。

关键词：中西医结合治疗;慢阻肺发作期;肺功能

[Abstract]Objective：To analyze the clinical effect of integrated traditional Chinese and western medicine on COPD onset. Methods：76 patients with COPD onset diagnosed and treated in our hospital from April 2020 to April 2021 were selected and divided into basic group and combined group by double-blind method（n=38）. The basic group was treated with conventional Western medicine，while the combined group was treated with integrated Chinese and Western medicine. The recovery of the two groups was compared. RESULTS：After treatment，lung function indexes in both groups were improved，and FEV1 and PEF indexes in combination group were more significantly improved than those in basic group（P < 0.05）. The rate of symptom remission in the combined group was 97.37%，and that in the basal group was 81.58%. The rate of symptom remission in the combined group was relatively higher（P < 0.05）. Conclusion：The treatment of integrated traditional Chinese and western medicine can effectively improve the pulmonary function of COPD patients，and the clinical treatment rate is high.

【Key words】Integrated Chinese and Western medicine treatment;COPD onset stage;Lung function

慢性阻塞性肺疾病為呼吸内科常见的症状类型，患者主要具有不完全可逆的气流受限特征，中老年患者数量居多。慢阻肺发作期指的是处于稳定期的患者受到感染、环境等因素影响，突然发病，对患者的肺功能及生命安全均会造成影响。常规临床多以西药控制方式为主，缓解患者的喘憋、咳嗽症状，但是患者病情易于反复发作，治疗效果不够理想。中医坚持辨证施治的原则，可基于患者的症状予以调节，改善患者的呼吸功能状态，缓解炎症反应。为了深入探究中西医结合治疗的效果，文章抽选2020年4月-2021年4月于本院诊治的76例慢阻肺发作期病例，根据患者恢复情况讨论，总结如下。

1  资料与方法

1.1 基础资料

本次研究抽选2020年4月-2021年4月于本院诊治的76例慢阻肺发作期病例，双盲法划入基础组与结合组（n=38）。结合组男女比值是20：18，年龄48-75岁，均龄值（60.07±4.57）岁。病程时间5-11年，均长值（6.93±1.28）年。基础组男女比值是22：16，年龄45-77岁，均龄值（60.19±4.22）岁。病程时间5-12年，均长值（7.11±1.13）年。两组基础数据对比无显著区别，可分组对照研究（p>0.05）。